| |
|
|
|
|
|
|
|||
|
C Leculier, N Couprie, A Francina, E Archimbaud, P Adeleine, D Treille, G Denoyel and D Fiere
Unite d'Immunologic, Institut Pasteur de Lyon, France.
A murine monoclonal antibody against human lysozyme (AHL MoAb) was produced
and tested on normal and leukemic monocytes using flow cytometry. The
antibody gave a positive reactivity on normal monocytes permeabilized by
saponin (82% to 98% of positive cells) and a negative reactivity on normal
permeabilized neutrophils. This monocyte-specific reactivity had not been
observed using a polyclonal antibody. Nevertheless, immunoblotting detected
lysozyme in both monocyte and polymorphonuclear leukocyte (PMNL) lysates.
The AHL MoAb, in the presence of lysozyme substrate (Micrococcus
lysodeikticus cell walls), strongly inhibited the enzymatic activity. Flow
cytometric analysis of leukemic cells isolated from patients suffering from
different subtypes of acute myeloid leukemia (French-American-British [FAB]
classification FAB M1-5) showed a highly significant positivity of FAB M5
for lysozyme compared with the other subtypes. The present results were
consistent with the detection of a lysozyme epitope by AHL MoAb located
near the catalytic site in monocytes. The same epitope was probably masked
in PMNL granules.
This article has been cited by other articles:
| |||||||||||
| Copyright © 1992 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||